Company Data
AlloVir Inc.
Ticker
ALVR
Price Target
Refer to Report
Volume
66.6K
52wk Range
$7.96 - $24.15
Overview
AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firmās pipeline includes ALVR106, ALVR109, ALVR108, and others. The companyās product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6.